This announcement is a separate document:
Bellevue Life Sciences Acquisition Corp. | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Hwang Kuk Hyoun
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.